|
⚲
|
| Keyboard |
| Mortimer Ian
✚
|
|
|---|---|
| CIK # | 0001619961 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001619961] | |
| 4 | [0001619961] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mortimer Ian | |
| Xenon Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-13 | Sell | 7,308 | $55.23 | 403,621 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-12 | Option exercise | 12,500 | ||
|
Xenon Pharmaceuticals Inc XENE
Restricted Share Units · derivative
|
2026-03-12 | Option exercise | 12,500 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-10 | Sell | 11,269 | $60.11 | 677,380 |
|
Xenon Pharmaceuticals Inc XENE
Stock Option · derivative
|
2026-03-09 | Option exercise | 105,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option · derivative
|
2026-03-09 | Option exercise | 75,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Stock Option · derivative
|
2026-03-09 | Option exercise | 65,000 | $0.00 | |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Option exercise | 20,000 | ||
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Sell | 65,000 | $62.06 | 4,033,900 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Option exercise | 65,000 | $9.44 | 613,600 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Sell | 61,652 | $60.08 | 3,704,052 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Sell | 43,348 | $59.26 | 2,568,802 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Option exercise | 105,000 | $4.75 | 498,750 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Sell | 2,449 | $61.26 | 150,026 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Sell | 10,072 | $60.47 | 609,054 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Sell | 12,479 | $59.50 | 742,500 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Option exercise | 25,000 | $3.10 | 77,500 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Sell | 21,515 | $60.49 | 1,301,442 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Sell | 31,694 | $59.88 | 1,897,837 |
|
Xenon Pharmaceuticals Inc XENE
Common Shares
|
2026-03-09 | Option exercise | 75,000 | $8.40 | 630,000 |
| showing 20 of 81 most recent transactions | |||||